Form D · Other Health Care
Los Angeles Biosciences, Inc.
Playa Del Rey, CA · CIK 0002074477
Offering snapshot reported Jun 24, 2025 · SEC filing
- Reported sold
- $4.87M Offering amount: $5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 9, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2025 | Initial | $4,869,444 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-549732
Source: Form D, filed Jun 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Derya L. Kelter | Director, Executive |
| Jeff Nichols | Executive |
| Ketan Patel | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
419 Waterview Street
Playa Del Rey, CA, 90293
Playa Del Rey, CA, 90293